CMS to Cut Lab Testing Reimbursement Rates by 15%; Quest Diagnostics Files Risk Disclosure
What happened
Centers for Medicare & Medicaid Services announced plans to cut reimbursement rates for lab testing by up to 15%, effective January 1, 2027. The cuts are intended to save taxpayers an estimated $1 billion per year. Quest Diagnostics filed a 10-K with the SEC highlighting the reduction in rates from Medicare and Medicaid as a key business risk.
From aol.com
Why it matters
The rate cuts follow a period where CMS was paying about 16% more for lab work than private insurers pay. For Quest Diagnostics, this directly impacts its revenue stream from these government programs. The company warned of potential impacts on testing volume and collected revenue.
From aol.com
Who's involved
- MedicareUS federal health insurance program whose payment structure is under review.
- Quest DiagnosticsMedical testing giant whose revenue relies on government reimbursement rates.
- SECRegulatory body requiring companies to file risk disclosures.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Quest DiagnosticsSpeculative
Quest Diagnostics could face reduced revenue due to the rate cuts affecting its business model.
- Corewell HealthSpeculative
Corewell Health might see a decline in revenue due to reduced testing volume caused by the rate cuts.
Keep exploring
The entities involved
-
Medicare
US federal health insurance
-
Quest Diagnostics
medical research company
-
SEC
Slovak company
Related events
- CMS proposes new payment rules for Medicare services, affecting reimbursement for Ambulatory Surgery Centers.
- CMS manages adjustments for Medicare Part B.
- CMS is running a pilot program that affects how Original Medicare services are delivered in the state of Ohio.
- CMS utilized predictive analytics against Medicare claims.
- CMS uses RVU and AMA standards to manage payment rules for Medicare physician labor.